A recent study by Baycrest reveals that an area of the brain distinct from the stroke lesion may play a significant role in causing the life-altering symptoms survivors are often left with, which can include severe challenges with speech, mobility and cognition.
PBMs aren’t opening access to lower-cost biosimilars. Reform is needed now
The Federal Trade Commission presents on Thursday its interim staff report, “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies.” It
August 1, 2024